HIGHLIGHTS
- who: Eric Felli from the Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland have published the article: Emerging Therapeutic Targets for Portal Hypertension, in the Journal: (JOURNAL)
- what: Knowledge of the PH mechanism underwent continuous development since the concept of splanchnic vasodilation contributing to increase portal pressure was introduced in the 1980s, providing for the first time a rationale for using splanchnic vasoconstrictors for the complications of PH.
- future: Clinical studies suggest that lanifibranor may promote fibrosis regression in patients with NASH although further studies are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.